Viyash Scientific Limited
VIYASH.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$102.16B
Close$
Share Statistics
| Market cap | $102.16 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $4.09 |
| Beta | 0.97 |
| Outstanding Shares | 436,438,560 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 55.86 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$2.02
Average shareholder expectationRevenue Estimate
$9.18 B
Average shareholder expectationNext Earnings Call
Expected Date
November 14, 2026
EPS Estimate
$1.90
Average shareholder expectationRevenue Estimate
$9.82 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Viyash Scientific Limited
1,244 employees
CEO: Haribabu Bodepudi Viyash Scientific Limited is a global veterinary healthcare company with operations spanning Europe, Asia, and other international markets. It specializes in developing and supplying finished dosage forms for a range of therapeutic appli...